ReviewFrontiers in public health2026
High-altitude hyperuricemia: a double-edged sword of adaptation and maladaptation.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyperuricemia is characterized by elevated serum uric acid levels and is associated with multiple diseases. Studies have consistently demonstrated that the prevalence of hyperuricemia in high-altitude areas is significantly higher than that in low-altitude areas. For high-altitude hyperuricemia, some environmental and genetic factors exhibit distinct characteristics among patients. Hyperuricemia also contributes to the onset and progression of a range of high-altitude-related disorders. Although studies have identified the characteristics of high-altitude hyperuricemia, the associations between elevated uric acid levels and influencing factors remain to be fully elucidated. This perspective compiles data from global epidemiological studies and clinical practices, and provides an exploration of the factors contributing to elevated uric acid levels at high altitudes. Additionally, we uncover the metabolic processes in patients with hyperuricemia and the correlation between hyperuricemia and high-altitude-related diseases, providing a foundation for developing more targeted therapeutic approaches and advanced pharmaceutical strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.